[1]
2024. Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study. Dermatology Practical & Conceptual. 14, 4 (Oct. 2024), e2024259. DOI:https://doi.org/10.5826/dpc.1404a259.